Chitosan nanoparticles targeted to the tumor-associated ganglioside GD2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chitosan nanoparticles targeted to the tumor-associated ganglioside GD2

Published:2016-09 Issue:5 Volume:42 Page:532-545
ISSN:1068-1620
Container-title:Russian Journal of Bioorganic Chemistry
language:en
Short-container-title:Russ J Bioorg Chem

Author:

Zubareva A. A.,Boyko A. A.,Kholodenko I. V.,Rozov F. N.,Larina M. V.,Aliev T. K.,Doronin I. I.,Vishnyakova P. A.,Molotkovskaya I. M.,Kholodenko R. V.

Publisher

Pleiades Publishing Ltd

Subject

Organic Chemistry,Biochemistry

Link

http://link.springer.com/content/pdf/10.1134/S1068162016050150.pdf

Reference30 articles.

1. Navid, F., Santana, V.M., and Barfield, R.C., Curr. Cancer Drug Targets, 2010, vol. 10, pp. 200–209.

2. Suzuki, M. and Cheung, N.K., Expert Opin. Ther. Targets, 2015, vol. 19, no. 3, pp. 349–362.

3. Battula, V.L., Shi, Y., Evans, K.W., Wang, R.Y., Spaeth, E.L., Jacamo, R.O., Guerra, R., Sahin, A.A., Marini, F.C., Hortobagyi, G., Mani, S.A., and Andreeff, M., J. Clin. Invest., 2012, vol. 122, pp. 2066–2078.

4. Doronin, I.I., Vishnyakova, P.A., Kholodenko, I.V., Molotkovskaya, I.M., Ponomarev, E.D., and Kholodenko, R.V., BMC Cancer, 2014, vol. 14, p. 295.

5. Deyev, S.M., Lebedenko, E.N., Petrovskaya, L.E., Dolgikh, D.A., Gabibov, A.G., and Kirpichnikov, M.P., Russ. Chem. Rev., 2015, vol. 84, pp. 1–26.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4;Current Issues in Molecular Biology;2023-10-05

2. Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells;International Journal of Molecular Sciences;2023-01-08

3. Smaller size packs a stronger punch - Recent advances in small antibody fragments targeting tumour-associated carbohydrate antigens;Theranostics;2023

4. Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies;Molecules;2019-10-24

5. Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations;Current Medicinal Chemistry;2019-03-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3